Mankind Pharma shares in focus after Q3 net profit rises 8%YoY to Rs 414 crore by ET Markets | February 4, 2026 10:11 am | Indian Stocks, Market, News The company reported an 8% year-on-year rise in Q3FY26 net profit to Rs 414 crore, while revenue grew 11.5% to Rs 3,567 crore, led by solid domestic growth and stronger export performance.
